Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/28/2008EP1925621A1 Crystalline forms of zoledronic acid
05/28/2008EP1925617A1 Heterocyclic compound, and production process and use thereof
05/28/2008EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects
05/28/2008EP1925314A1 Pharmaceutical composition with synergistic anticonvulsant effect
05/28/2008EP1925309A1 Novel anticancer concomitant drug
05/28/2008EP1925308A1 Low hygroscopic aripiprazole (crystal G) drug substance and processes for the preparation thereof
05/28/2008EP1925307A1 Use of 3-alpha-androstanediol in the treatment of sexual dysfunction
05/28/2008EP1925306A2 Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure
05/28/2008EP1925305A1 Ih channel inhibitors for the promotion of wakefulness
05/28/2008EP1925304A1 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
05/28/2008EP1925303A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure
05/28/2008EP1925302A1 Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression
05/28/2008EP1925301A1 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
05/28/2008EP1925299A1 Adhesive patch less irritative to skin
05/28/2008EP1925297A1 Method for preparing microparticles having a selected polymer molecular weight
05/28/2008EP1925296A1 Stable powder formulation containing a new antichinolinergic agent
05/28/2008EP1924618A1 Bile acid sequestrant and process for preparation thereof
05/28/2008EP1924592A2 Process for the synthesis of rocuronium bromide
05/28/2008EP1924587A1 A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
05/28/2008EP1924585A1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
05/28/2008EP1924584A1 Use of fused imidazole derivatives to mediate ccr3 related conditions
05/28/2008EP1924582A2 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods
05/28/2008EP1924581A1 Hydroxy substituted 1h-imidazopyridines and methods
05/28/2008EP1924580A1 Non-steroidal compounds useful as glucocorticoid receptor modulators
05/28/2008EP1924579A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
05/28/2008EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
05/28/2008EP1924576A1 The ocean wave energy converter (owec)
05/28/2008EP1924573A1 B-raf inhibitors
05/28/2008EP1924571A2 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
05/28/2008EP1924570A1 Azole and thiazole derivatives and their use
05/28/2008EP1924568A1 Quinazoline derivatives useful in cancer treatment
05/28/2008EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators
05/28/2008EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1924563A1 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
05/28/2008EP1924561A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/28/2008EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/28/2008EP1924558A1 An antimalarial baylis-hillman adducts and a process for the preparation thereof
05/28/2008EP1924557A2 Carbazole derivatives
05/28/2008EP1924556A2 Crystalline forms of atorvastatin
05/28/2008EP1924554A1 Sulphonamide derivatives
05/28/2008EP1924553A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
05/28/2008EP1924548A2 Ester prodrugs of prostratin and related phorbol compounds
05/28/2008EP1924327A2 Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
05/28/2008EP1924326A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
05/28/2008EP1924325A2 Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure
05/28/2008EP1924300A2 Porous coating loaded with a liquid or a solid substance
05/28/2008EP1924299A1 Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
05/28/2008EP1924294A2 Compositions and their uses directed to ptpru
05/28/2008EP1924289A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
05/28/2008EP1924274A1 Modulation of cell fates and activities by phthalazinediones
05/28/2008EP1924270A2 Iron (iii) complex compounds for treating iron deficiency in patients with chronic inflammatory intestinal diseases
05/28/2008EP1924269A2 Vegetation water composition for treatment of inflammatory skin conditions
05/28/2008EP1924267A2 Staurosporine derivatives for treating non-small cell lung cancer
05/28/2008EP1924266A2 Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events
05/28/2008EP1924265A2 Chemokine receptor binding compounds
05/28/2008EP1924264A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
05/28/2008EP1924263A2 Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
05/28/2008EP1924262A2 Methods and formulations for modulating lyn kinase activity and treating related disorders
05/28/2008EP1924261A1 Stable solid formulation of sertindole
05/28/2008EP1924260A2 Use of cxcr4 binding molecules for the treatment of whim syndrome
05/28/2008EP1924259A2 Inhibition of intermediate-conductance calcium activated potassium channels in the treatment and/or prevention of atherosclerosis
05/28/2008EP1924258A1 IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF
05/28/2008EP1924257A1 Stabilized 3-hydroxyflavan compositions and methods therefor
05/28/2008EP1924256A1 Composition comprising a dendrimer and the use thereof for binding phosphate
05/28/2008EP1924255A1 Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
05/28/2008EP1924254A2 Use of tellurium compounds for protection from ultra-violet radiation
05/28/2008EP1924253A2 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
05/28/2008EP1924252A2 Method for improving cell permeability to foreign particles
05/28/2008EP1924251A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts
05/28/2008EP1924250A2 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
05/28/2008EP1924247A2 Liposome compositions
05/28/2008EP1924154A1 Food supplement
05/28/2008EP1924143A2 O-nitro compounds, pharmaceutical compositons thereof and uses thereof
05/28/2008EP1863817B1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
05/28/2008EP1828194B1 Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
05/28/2008EP1814895A4 Apparatus and system having dry control gene silencing compositions
05/28/2008EP1781644B1 Macrocyclic beta-secretase inhibitors
05/28/2008EP1778709B1 Polysulfated glycosides and salts thereof
05/28/2008EP1768954A4 2-methylpropanamides and their use as pharmaceuticals
05/28/2008EP1756118B1 Tetrahydropyridothiophenes for use in the treatment of cancer
05/28/2008EP1753422B1 Small molecule inhibitors for mrp1 and other multidrug transporters
05/28/2008EP1741425B1 Novel antiviral pharmaceutical composition
05/28/2008EP1718147A4 Hemostatic agent for topical and internal use
05/28/2008EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
05/28/2008EP1701940B1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
05/28/2008EP1701741B1 Complexes having adjuvant activity
05/28/2008EP1699446B1 Compositions and methods for treating hepatitis c virus (hcv) infection
05/28/2008EP1692123B1 Phenyl-furan compounds as vitamin d receptor modulators
05/28/2008EP1691805B1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person
05/28/2008EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
05/28/2008EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors
05/28/2008EP1658039B1 Use of biotin or a biotin derivative with vitamin c for lightening skin and treating age spots
05/28/2008EP1635806B1 Method for treating alcoholic hepatitis
05/28/2008EP1633355B1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
05/28/2008EP1620069B1 Warming and nonirritating lubricant fungicide compositions in the form of a gel
05/28/2008EP1605946B1 Thiazoles useful as inhibitors of protein kinases
05/28/2008EP1603891B1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
05/28/2008EP1599471B1 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
05/28/2008EP1592405B1 Composition for chemoembolotherapy of solid tumors
1 ... 3246 3247 3248 3249 3250 3251 3252 3253 3254 3255 3256 3257 3258 3259 3260 3261 3262 3263 3264 3265 3266 ... 7860